5 Best Services Stocks To Watch Right Now

Apple (NASDAQ: AAPL  ) has been working hard to rid its iOS platform of Google (NASDAQ: GOOG  ) services. The Siri personal assistant wants to replace Google searches in many cases, and then there's the Apple Maps debacle that followed when Google's mapping app was given the boot from your default iPhone and iPad screen.

But Google is not above writing iOS apps like any other third-party developer, and has gained or regained significant footholds in various parts of Apple's world. In the video below, Fool contributor Anders Bylund discusses the current state of Google on iOS hardware in the light of fresh data from mobile security firm Onavo. For example, 32% of iPhone users are back to using Google maps even if they have to find and install it by hand. In some cases, Apple users flock to Google alternatives that can't offer any real benefits due to Apple's rigorous limits on developer choices. Which begs the question: Why won't Apple turn this subtle platform invasion around? Anders has the answer to that mystery, too.

Hot Dow Dividend Stocks To Invest In Right Now: National Asset Recovery Corp (REPO)

National Asset Recovery Corp., formerly Nasus Consulting, Inc., incorporated on August 1, 2000, is a development-stage company. The Company focuses to design, develop and bring to market an immersive three dimensional (3D) virtual world, which provides an online, consumer entertainment experience that combines multiplayer gaming, virtual world and social networking elements.

On May 27, 2009, the Company ceased its information technology business. As of December 31, 2009, the Company had not recorded any revenues from its new business operations.

Advisors' Opinion:

• [By Chandan Dubey]

  Banks also borrow money from insurance companies and pension funds where the funds are non-depository in nature. These loans are generally collateralized against Treasuries or securities. These are called repurchase agreements (repo) and are mostly overnight. The funds are returned the next day with the interest.

5 Best Services Stocks To Watch Right Now: Gen-Probe Incorporated(GPRO)

Gen-Probe Incorporated engages in the development, manufacture, and marketing of molecular diagnostic products and services that are used primarily to diagnose human diseases and screen donated human blood. Its women?s health product line includes APTIMA Combo 2 assay, APTIMA CT, APTIMA GC assays, and PACE family of assays to detect chlamydia and gonorrhea; APTIMA Trichomonas ASRs to detect trichomonas; APTIMA HPV assay to detect 14 sub-types of high-risk HPV associated with cervical cancer; and AccuProbe Group B Streptococcus (GBS) assay to detect GBS from culture. The company?s infectious diseases product line comprises ProFlu+ to detect influenza A, B, and Respiratory syncytial virus; ProFAST+ to detect and differentiate seasonal H1, seasonal H3, and H1N1pdm09; ProGastro Cd to detect toxigenic strains of clostridium difficile; AMPLIFIED MTD to detect mycobacterium tuberculosis; GAS Direct to detect gas directly from a throat swab; APTIMA HIV-1 and APTIMA HCV assays to detect RNA from HIV-1 and hepatitis C virus; and ASRs for quantitative HCV testing. Its blood screening products include Procleix HIV-1/HCV, Procleix Ultrio, Procleix Ultrio Plus, and Procleix WNV assays to detect HIV-1, HCV, HBV, and west nile virus in donated blood, plasma, organs, and tissues. The company?s transplant diagnostics products comprise LIFECODES HLA DNA typing kits; LIFECODES HLA antibody kits; LIFECODES PF4 assay to detect PF4 heparin-dependent antibodies; and LIFECODES PAK products for platelet antibody screening and detection. It also provides instrumentation and software for performing NAT assays; and genetic testing products, such as PROGENSA PCA3 and PCA3 ASRs to detect the PCA3 genes. The company serves reference laboratories, public health institutions, and hospitals through its direct sales force in United States, Canada, and Europe, as well as through distributors internationally. Gen-Probe Incorporated was founded in 1983 and is headquartered in S an Diego, California.

Advisors' Opinion:

• [By Garrett Cook]

  GoPro (NASDAQ: GPRO) shares were also up, gaining 12.91 percent to $77.06 after the company reported better-than-expected third-quarter results and issued a strong forecast for the fourth quarter.

• [By Matt Egan]

  The IPO surge was headlined by companies like GoPro (GPRO) and Weibo (WB), sometimes dubbed China's Twitter. They wanted to take advantage of the rising stock market and investor appetite for the next big thing.

• [By reports.droy]

  The digital-sports camera maker, GoPro (GPRO), went public this June and in fact this was the first-quarter earnings release after its formal IPO. Last Thursday, after the company disclosed its third-quarter results, analysts cheered and GoPro�� shares which had gone down tumbling in early October surged 19% to a high of $81.13 making investors throw a sigh of relief. So is there a growing demand for GoPro�� product mix? How did it fare in the third quarter ��was it so impressive as indicated through the stock movement. Let�� peek into the quarter highlights to derive the final answer.

• [By WWW.DAILYFINANCE.COM]

  gopro.com If a thrill-seeking mountain biker wants to take on some choppy terrain, it might not be a bad idea to ride GoPro's (GPRO) stock chart. One of the market's most volatile stocks is the maker of wearable cameras that extreme sporting enthusiasts -- like our mountain biker here -- don to record their feats of fancy. It's been a tale of two quarters for GoPro in its first six months as a public company. GoPro went public at $24 in late June, soaring in subsequent weeks. It peaked in early October, more than quadrupling to hit $98.47. It has gone on to shed more than 40 percent of its value. The wild swings aren't a surprise. GoPro went public with plenty of hype this summer, and valuation concerns were bound to come up after it roared out of the gate. Why was GoPro so hot six months ago? Why has it been so cold this quarter? Let's take a look at the two sides of the GoPro mania. Meet the Hot IPO of 2014 It's easy to see why investors gravitated toward GoPro. We've all seen those breathtaking helmet-mounted high-def videos of skateboarders, skiers and hang gliders, and GoPro is the wearable camera of choice for adrenaline junkies like these. GoPro came to market with the speed of some of its action videos. Revenue more than doubled in 2012, and nearly did so again in 2013 when its top line soared 87 percent to hit $985.7 million. Earnings and operating profits were also on a tear. Another thing that helped GoPro was that it more than lived up to the hype. It posted better-than-expected earnings in its first two quarterly reports as a public company, and first impressions for Wall Street debutantes linger. Investors sometimes stay away from hardware plays, especially in a cutthroat market like video cameras. However, GoPro made it clear at the time of its IPO that its grander goal was to become a media company. It wanted to tap into the growing content created by GoPro users to create a social video platform of its own. It went on to hire Guggenheim

5 Best Services Stocks To Watch Right Now: Cenkos Securities PLC (CNKS)

Cenkos Securities plc (Cenkos) is an independent, specialist institutional securities group, focused on growth companies and investment funds. The Company�� principal activities comprise of corporate broking and advisory and institutional equities. Corporate Broking and Advisory segment reflects the corporate finance, corporate broking and market making services provided to growth companies and investment funds. Institutional Equities segment reflects the institutional equities team who provide research-driven investment recommendations and execution capabilities to institutional clients. Cenkos earns fees from primary and secondary equity fund raising, acting as a key intermediary between growth companies or investment funds and institutional providers of capital. Revenue in Corporate Broking and Advisory segment is made up of placing commissions on fund raisings, corporate finance fees and retainer income, market making profits and commissions on secondary market transactions. Advisors' Opinion:

• [By Trista Kelley]

  Cenkos Securities Plc (CNKS) is running the spinoff and the share sale. Royal DSM NV (DSM), the world�� largest maker of vitamins, holds about 9 percent of SiS, while U.K. venture-capital trust Downing LLP owns 16.7 percent, Moon said. Provexis stockholders received one share of Science in Sport for every 100 shares of Provexis.

5 Best Services Stocks To Watch Right Now: ExamWorks Group Inc. (EXAM)

ExamWorks Group, Inc., together with its subsidiaries, provides independent medical examinations (IME), peer and bill reviews, and related services in the United States, Canada, the United Kingdom, and Australia. Its IME services are used by clients to confirm the veracity of claims by sick or injured individuals for workers� compensation, automotive, personal injury liability, and disability insurance coverage. The company also offers peer review services, including medical record reviews, nurse file reviews, and utilization reviews by members of its medical panel to provide medical opinion of a claimant�s condition and treatment; bill review services, such as physician and hospital bill reviews, and surgical cost estimates; and other IME related services comprising litigation support, medical record retrieval, administrative support services, and managed technology services. ExamWorks Group, Inc. provides its services through its medical panel of independently contract ed physicians and other medical providers. It serves property and casualty insurance carriers, law firms, third-party claim administrators, government agencies, and state funds. The company was incorporated in 2007 and is headquartered in Atlanta, Georgia.

Advisors' Opinion:

• [By Roberto Pedone]

  Examworks Group (EXAM) is a provider of independent medical examinations, peer and bill reviews and related services. This stock closed up 9.4% at $24.28 in Wednesday's trading session.

  Wednesday's Volume: 1.62 million
  
  Three-Month Average Volume: 209,788
  
  Volume % Change: 583%

  From a technical perspective, EXAM exploded higher here right off some near-term support at $21.91 with heavy upside volume. This stock has been uptrending strong for the last six months, with shares soaring higher from its low of $13.79 to its intraday high of $24.40. During that uptrend, shares of EXAM have been consistently making higher lows and higher highs, which is bullish technical price action. This move also pushed shares of EXAM into breakout territory, since the stock took out its former 52-week high at $23.56.

   

  Traders should now look for long-biased trades in EXAM as long as it's trending above $23 or $22.50 and then once it sustains a move or close above Wednesday's high of $24.40 with volume that hits near or above 209,788 shares. If we get that move soon, then EXAM will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $28 to $30.